When No Additional Testing Is a Decision Worth Documenting

Lukas
By

Some changes may not require further execution. The work lies in establishing why that conclusion fits the system and preserving the basis for someone who reviews it later.

Define the assessed change precisely

Identify the source, version and actual effect. A supplier’s description can inform the assessment, but the team should establish whether the description applies to its configuration. If the release changes several components, separate the portion covered by the decision from any portion still under review.

Consider a hypothetical update to help text on an unused administrative screen. The team may conclude that controlled workflows and data behavior remain unchanged. That conclusion should identify how applicability was checked and whether the screen or underlying component is used elsewhere in the process.

Connect the rationale to existing evidence

Explain which requirements and controls remain satisfied and why the earlier evidence is still relevant. The justification may reference design information, supplier documentation or a focused inspection. The selected approach should match the risk and the organization’s procedures.

Avoid reasoning from absence alone. A missing link in a traceability matrix does not demonstrate that a change has no effect. Likewise, a lack of reported incidents does not prove unchanged behavior. The record should show an affirmative basis for the conclusion.

State the limits of the decision

Identify assumptions that would reopen the assessment, such as activation of a new feature or a revised supplier release note. A decision can be appropriate within a defined scope while requiring reassessment when that scope changes. Making the boundary explicit improves future maintenance.

Validfor’s change workflow can be evaluated for how it captures assessment reasoning and approval. Its AI policy retains human judgment over recommendations. This combination is useful when the team wants AI assistance with impact analysis while preserving a clear owner for the final scope decision.

A concise rationale can be sufficient when it answers the relevant questions. What matters is whether the conclusion can be reconstructed from the accepted record.

In recent years, validation processes across the pharmaceutical industry have been undergoing a major transformation. Workflows that were traditionally managed through paper documentation, spreadsheets and manual review cycles are increasingly moving toward digital validation platforms. As a result, life sciences organizations often evaluate solutions such as Kneat, Validfor, ValGenesis, MasterControl and Veeva when modernizing validation lifecycle management and compliance documentation.

Share This Article